drugset / Trial / NCT00723437

Evaluation of the Efficacy of Acitretin Therapy for Nail Psoriasis

NCT00723437

NaSingle-groupOpen-label

Summary

Objective: Efficacy of systemic retinoid therapy of nail psoriasis has never been assessed objectively. Evaluate therapeutic efficacy of acitretin in patients with isolated nail psoriasis. Design: Open-study on thirty-six patients with moderate to severe nail psoriasis treated with acitretin. Participants: Patients included 27 men and 9 women (mean age 41) with nail psoriasis. Intervention: Therapy consisted of acitretin 0.2 to 0.3 mg/Kg/day for 6 months. Main Outcome Measure(s): Clinical evaluation, NAPSI and modified NAPSI scores before therapy, every 2 months during therapy and 6 months after treatment.

Timeline

Start
2005-01
Primary completion
2007-01
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Acitretin Small molecule 0.2 mg/kg
Subject Acitretin Small molecule 0.3 mg/kg

Indications